Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ulmer

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
Research Square|September 2, 2025
A Multi-Antigen Broad-Spectrum Coronavirus Vaccine Induces Potent and Durable Cross-Protection Against Infection and Disease Caused by Multiple SARS-CoV-2 VariantsSwayam Prakash, Nisha R Dhanushkodi, Afshana Quadiri, et al.
Advances in Genetics|January 27, 2015
Self-amplifying mRNA vaccinesLuis A Brito, Sushma Kommareddy, Domenico Maione, et al.
Journal of Virology|October 16, 2015
Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus HemagglutininMichela Brazzoli, Diletta Magini, Alessandra Bonci, et al.
Journal of Virology|September 27, 2003
Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolateIndresh K Srivastava, Leonidas Stamatatos, Elaine Kan, et al.
Virology|December 7, 2007
Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolatesIndresh K Srivastava, Elaine Kan, Yide Sun, et al.
Human Vaccines & Immunotherapeutics|July 4, 2025
A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variantsHawa Vahed, Swayam Prakash, Afshana Quadiri, et al.
AIDS Research and Human Retroviruses|July 16, 2008
A therapeutic SIV DNA vaccine elicits T-cell immune responses, but no sustained control of viremia in SIVmac239-infected rhesus macaquesJan zur Megede, Brigitte Sanders-Beer, Peter Silvera, et al.
Nature Medicine|August 1, 1996
Immunogenicity and protective efficacy of a tuberculosis DNA vaccineK Huygen, J Content, O Denis, et al.
Journal of Virology|October 18, 2005
Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strainYing Lian, Indresh Srivastava, V Rául Gómez-Román, et al.
Journal of Virology|March 7, 2014
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responsesAlicja M Chmielewska, Mariarosaria Naddeo, Stefania Capone, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Research Square|September 2, 2025
A Multi-Antigen Broad-Spectrum Coronavirus Vaccine Induces Potent and Durable Cross-Protection Against Infection and Disease Caused by Multiple SARS-CoV-2 VariantsSwayam Prakash, Nisha R Dhanushkodi, Afshana Quadiri, et al.
Advances in Genetics|January 27, 2015
Self-amplifying mRNA vaccinesLuis A Brito, Sushma Kommareddy, Domenico Maione, et al.
Journal of Virology|October 16, 2015
Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus HemagglutininMichela Brazzoli, Diletta Magini, Alessandra Bonci, et al.
Journal of Virology|September 27, 2003
Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolateIndresh K Srivastava, Leonidas Stamatatos, Elaine Kan, et al.
Virology|December 7, 2007
Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolatesIndresh K Srivastava, Elaine Kan, Yide Sun, et al.
Human Vaccines & Immunotherapeutics|July 4, 2025
A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variantsHawa Vahed, Swayam Prakash, Afshana Quadiri, et al.
AIDS Research and Human Retroviruses|July 16, 2008
A therapeutic SIV DNA vaccine elicits T-cell immune responses, but no sustained control of viremia in SIVmac239-infected rhesus macaquesJan zur Megede, Brigitte Sanders-Beer, Peter Silvera, et al.
Nature Medicine|August 1, 1996
Immunogenicity and protective efficacy of a tuberculosis DNA vaccineK Huygen, J Content, O Denis, et al.
Journal of Virology|October 18, 2005
Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strainYing Lian, Indresh Srivastava, V Rául Gómez-Román, et al.
Journal of Virology|March 7, 2014
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responsesAlicja M Chmielewska, Mariarosaria Naddeo, Stefania Capone, et al.
Pageof 18